HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Supplemental Data All Versions of this Article: 2007-0248v1 25/10/2559    most recent Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints/Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Vieyra, D. S. Articles by Goodell, M. A. Search for Related Content PubMed PubMed Citation Articles by Vieyra, D. S. Articles by Goodell, M. A.

EMBRYONIC STEM CELLS

Pluripotentiality and Conditional Transgene Regulation in Human Embryonic Stem Cells Expressing Insulated Tetracycline-ON Transactivator

Stem Cells and Regenerative Medicine Center and Center for Cell and Gene Therapy, Department of Pediatrics, Baylor College of Medicine, Houston, Texas, USA

Key Words. Human embryonic stem cells • Tetracycline-ON transactivator • Insulated lentivector • Pluripotency Conditional expression

Correspondence: Margaret Goodell, Ph.D., Stem Cells and Regenerative Medicine Center, Baylor College of Medicine, One Baylor Plaza, N1030, Houston, Texas 77030, USA. Telephone: 713-798-1265; Fax: 713-798-1230; e-mail: Goodell{at}bcm.edu

Received April 2, 2007; accepted for publication July 2, 2007.
First published online in STEM CELLS EXPRESS   July 12, 2007.



Conditional manipulation of gene expression by using tetracycline (TET)-ON based approaches has proven invaluable to study fundamental aspects of biology; however, the functionality of these systems in human embryonic stem cells (hESC) has not been established. Given the sensitivity of these cells to both genetic manipulation and variations of culture conditions, constitutive expression of TET transactivators might not only be toxic for hESC but might also impair their ability to self-renew or differentiate into multiple tissues. Therefore, the effect of these transactivators on the biology and pluripotentiality of hESC must first be evaluated before broad use of TET-ON methodologies is applied in these cells. Improved insulated lentivectors that display stable transgene expression and minimal insertional transactivation have been described for hESC. By using insulated lentivectors that allow simultaneous expression of TET components and fluorescent reporters, here we demonstrate that hESC constitutively expressing the TET-ON transactivator rtTA2SM2 can be derived and expanded in culture while retaining inducible transgene expression and pluripotentiality, including marker expression, a normal karyotype, and the ability to generate multiple tissues of different germ layer origin in teratomas. We also show that these cells retain the ability to control the expression of a stable integrated transgene in a doxycycline-dependent manner, which demonstrates that an insulated TET-ON lentiviral system is functional in hESC. Together, our results indicate that improved TET regulators like rtTA2SM2 in combination with insulated lentiviral-based systems offer alternative strategies for conditional gene expression in hESC.

Disclosure of potential conflicts of interest is found at the end of this article.

This article has been cited by other articles:

				C. Unger, E. Karner, A. Treschow, B. Stellan, U. Felldin, H. Concha, M. Wendel, O. Hovatta, A. Aints, L. Ahrlund-Richter, et al. Lentiviral-Mediated HoxB4 Expression in Human Embryonic Stem Cells Initiates Early Hematopoiesis in a Dose-Dependent Manner but Does Not Promote Myeloid Differentiation Stem Cells, October 1, 2008; 26(10): 2455 - 2466. [Abstract] [Full Text] [PDF]

				X. Xia, M. Ayala, B. R. Thiede, and S.-C. Zhang In Vitro- and In Vivo-Induced Transgene Expression in Human Embryonic Stem Cells and Derivatives Stem Cells, February 1, 2008; 26(2): 525 - 533. [Abstract] [Full Text] [PDF]